Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9

Thrombosis Journal

Volumn 8, Issue , 2010, Pages

  Kaneider, Nicole C ^a   Mosheimer, Birgit ^a   Günther, Andrea ^b   Feistritzer, Clemens ^a   Wiedermann, Christian J ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; FIBRINOGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; AUTOCRINE EFFECT; BLOOD CLOTTING TIME; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; REGULATORY MECHANISM;

EID: 77649296254     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-8-2     Document Type: Article

References (23)

1. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joo GB, Godal HC, Skjonsberg OH. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost 2007, 97:822-829.
2. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001, 167:2887-2894.
3. Sitrin RG, Pan PM, Srikanth S, Todd RF. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol 1998, 161:1462-1470.
4. Rubel C, Fernandez GC, Rosa FA, Gomez S, Bompadre MB, Coso OA, Isturiz MA, Palermo MS. Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J Immunol 2002, 168:3527-3535.
5. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987, 235:1348-1352. 10.1126/science.3029867, 3029867.
6. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993, 91:2850-2860. 10.1172/JCI116529, 443354, 8514893.
7. Esmon CT, Taylor FB, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991, 66:160-165.
8. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989, 109:389-395. 10.1083/jcb.109.1.389, 2115486, 2663880.
9. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989, 134:1087-1097. 1879887, 2719077.
10. Flick MJ, Du X, Degen JL. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood) 2004, 229:1105-1110.
11. Forsyth CB, Solovjov DA, Ugarova TP, Plow EF. Integrin alpha(M)beta(2)-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med 2001, 193:1123-1133. 10.1084/jem.193.10.1123, 2193326, 11369784.
12. Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci 2001, 936:368-385.
13. Stefanidakis M, Bjorklund M, Ihanus E, Gahmberg CG, Koivunen E. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins. J Biol Chem 2003, 278:34674-34684. 10.1074/jbc.M302288200, 12824186.
14. Kaneider NC, Leger AJ, Kuliopulos A. Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions. FEBS J 2006, 273:4416-4424. 10.1111/j.1742-4658.2006.05441.x, 16956369.
15. Ritchie DG, Levy BA, Adams MA, Fuller GM. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Natl Acad Sci USA 1982, 79:1530-1534. 10.1073/pnas.79.5.1530, 346008, 6461860.
16. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 1995, 92:1505-1509. 10.1073/pnas.92.5.1505, 42548, 7878009.
17. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993, 73:1423-1434. 10.1016/0092-8674(93)90367-Y, 8100742.
18. Lishko VK, Podolnikova NP, Yakubenko VP, Yakovlev S, Medved L, Yadav SP, Ugarova TP. Multiple binding sites in fibrinogen for integrin alphaMbeta2 (Mac-1). J Biol Chem 2004, 279:44897-44906. 10.1074/jbc.M408012200, 15304494.
19. Minson CT, Green DJ. Measures of vascular reactivity: prognostic crystal ball or Pandora's box?. J Appl Physiol 2008, 105:398-399. 10.1152/japplphysiol.90741.2008, 18556427.
20. Canobbio I, Reineri S, Sinigaglia F, Balduini C, Torti M. A role for p38 MAP kinase in platelet activation by von Willebrand factor. Thromb Haemost 2004, 91:102-110.
21. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR. Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 1995, 270:696-699. 10.1074/jbc.270.2.696, 7822297.
22. Flick MJ, La Jeunesse CM, Talmage KE, Witte DP, Palumbo JS, Pinkerton MD, Thornton S, Degen JL. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest 2007, 117:3224-3235. 10.1172/JCI30134, 2000806, 17932565.
23. Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 2007, 204:571-2582. 10.1084/jem.20061931, 2137908, 17339406.